V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161302 | 20062329 | 1.5 | 53.4 | Palliative (P) | 2016-11-18 | 2016-11-24 | ECX | N | N | ECX | 101191801 |
| 20161304 | 20062330 | 1.72 | 74.6 | Neo-adjuvant (N) | 2016-09-08 | 2016-09-27 | ECX | N | N | ECX | 100902815 |
| 20161306 | 20062331 | 1.47 | 62 | Neo-adjuvant (N) | 2019-12-17 | 2020-01-14 | ECX | 02 | N | ECX | 100231188 |
| 20161307 | 20062332 | 1.71 | 64.6 | Neo-adjuvant (N) | 2019-01-09 | 2019-01-11 | ECX | N | N | ECX | 101522678 |
| 20161308 | 20062333 | 1.74 | 77.3 | Neo-adjuvant (N) | 2019-02-13 | 2019-02-14 | ECX | 02 | N | ECX | 101748768 |
| 20161309 | 20062334 | 1.61 | 57.9 | Neo-adjuvant (N) | 2017-06-03 | 2017-06-16 | ECX | N | null | ECX | 101249180 |
| 20161310 | 20062335 | 1.8 | 93 | Neo-adjuvant (N) | 2018-01-13 | 2018-01-14 | ECX | 02 | N | ECX | 101157564 |
| 20161312 | 20062336 | 1.7 | 79 | Palliative (P) | null | 2019-11-01 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100304260 |
| 20161313 | 20062337 | 1.49 | 61.9 | Neo-adjuvant (N) | 2020-01-23 | 2020-01-24 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101069451 |
| 20161314 | 20062338 | 1.6 | 46 | Curative (C) | 2016-10-22 | 2016-10-28 | ECX | 02 | N | ECX | 101827517 |
| 20161318 | 20062339 | 1.86 | 78.6 | Curative (C) | 2018-07-06 | 2018-07-12 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100454801 |
| 20161319 | 20062340 | 1.68 | 57.3 | Neo-adjuvant (N) | 2017-02-24 | 2017-03-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100805410 |
| 20161320 | 20062341 | 1.87 | 55.2 | Neo-adjuvant (N) | 2018-12-17 | 2019-01-13 | ECX | 2 | N | ECX | 100947820 |
| 20161321 | 20062342 | 1.64 | 90.4 | Neo-adjuvant (N) | 2016-05-31 | 2016-06-17 | ECX | N | N | ECX | 100934670 |
| 20161322 | 20062343 | 1.76 | 80 | null | 2018-03-10 | 2018-03-22 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101106981 |
| 20161323 | 20062344 | 1.65 | 60.7 | Neo-adjuvant (N) | 2018-12-03 | 2019-01-02 | ECX | N | N | ECX | 101774049 |
| 20161326 | 20062345 | 1.67 | 64 | Palliative (P) | 2019-05-19 | 2019-06-11 | ECX | N | N | ECX | 101823929 |
| 20161327 | 20062346 | 1.64 | 72 | Neo-adjuvant (N) | 2018-02-07 | 2018-02-21 | ECX | N | Y | ECX | 101137296 |
| 20161328 | 20062347 | 1.6 | 74.9 | Neo-adjuvant (N) | 2018-06-10 | 2018-06-23 | ECX | N | N | ECX | 101662313 |
| 20161329 | 20062348 | 1.71 | 95 | null | 2019-05-29 | 2019-05-31 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100318002 |
| 20161330 | 20062349 | 1.81 | 73.2 | Palliative (P) | 2018-04-27 | 2018-04-27 | ECX | 2 | N | ECX | 101674831 |
| 20161331 | 20062350 | 1.52 | 60 | Adjuvant (A) | 2018-09-11 | 2018-09-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100720897 |
| 20161332 | 20062351 | 1.67 | 91 | Adjuvant (A) | 2017-12-03 | 2017-12-03 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101372794 |
| 20161336 | 20062352 | 1.58 | 59.8 | Neo-adjuvant (N) | 2018-01-17 | 2018-01-22 | ECX | N | N | ECX | 100360077 |
| 20161337 | 20062353 | 1.6 | 68.9 | Palliative (P) | 2017-03-26 | 2017-03-30 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101752068 |
| 20161340 | 20062354 | 1.77 | 52.4 | Neo-adjuvant (N) | 2019-10-17 | 2019-10-17 | ECX | N | N | ECX | 101086745 |
| 20161341 | 20062355 | 1.55 | 71.5 | Adjuvant (A) | 2019-11-02 | 2019-11-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100495155 |
| 20161342 | 20062356 | 1.8 | 88.4 | Palliative (P) | null | 2016-08-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100577255 |
| 20161344 | 20062357 | 1.6 | 48.5 | Neo-adjuvant (N) | 2017-08-17 | 2017-08-17 | ECX | 02 | N | ECX | 100448302 |
| 20161346 | 20062358 | 1.68 | 72.4 | Adjuvant (A) | 2017-03-01 | 2017-04-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101197657 |
| 20161347 | 20062359 | 1.83 | 68.4 | Palliative (P) | 2016-03-08 | 2016-03-14 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101645885 |
| 20161348 | 20062360 | 1.48 | 77.5 | Palliative (P) | 2020-01-25 | 2020-01-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100499000 |
| 20161349 | 20062361 | 1.79 | 74 | Neo-adjuvant (N) | 2017-01-29 | 2017-02-08 | ECX | N | null | ECX | 101728978 |
| 20161350 | 20062362 | 1.72 | 64.7 | Palliative (P) | 2017-07-26 | 2017-08-16 | CAPECITABINE + GEMCITABINE | 01 | Y | CAPECITABINE + GEMCITABINE | 100135627 |
| 20161351 | 20062363 | 1.64 | 61.8 | null | 2018-06-25 | 2018-06-26 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101720789 |
| 20161353 | 20062364 | 1.71 | 69.2 | Palliative (P) | 2019-06-11 | 2019-06-25 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101140712 |
| 20161354 | 20062365 | 1.81 | 64.5 | Neo-adjuvant (N) | 2019-01-06 | 2019-01-13 | ECX | N | N | ECX | 101134380 |
| 20161355 | 20062366 | 1.65 | 70.7 | Neo-adjuvant (N) | 2018-08-07 | 2018-08-21 | ECX | null | N | ECX | 100419078 |
| 20161356 | 20062367 | 1.65 | 77.5 | Palliative (P) | 2017-01-02 | 2017-01-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100087950 |
| 20161357 | 20062368 | 1.58 | null | Curative (C) | 2017-09-09 | 2017-09-18 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100539916 |
| 20161358 | 20062369 | 1.7 | 83.7 | Neo-adjuvant (N) | 2019-02-08 | 2019-02-08 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100930562 |
| 20161359 | 20062370 | 1.64 | 78.9 | Palliative (P) | 2018-06-25 | 2018-07-04 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100756425 |
| 20161362 | 20062371 | 1.65 | 59 | Palliative (P) | 2019-04-25 | 2019-05-09 | ECX | 02 | N | ECX | 100354827 |
| 20161363 | 20062372 | null | null | Palliative (P) | 2019-12-21 | 2019-12-21 | ECX | 2 | N | ECX | 101191581 |
| 20161364 | 20062373 | 1.62 | 59.7 | null | 2020-01-16 | 2020-01-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100378809 |
| 20161366 | 20062374 | 1.75 | 86 | Palliative (P) | 2018-12-12 | 2018-12-15 | ECX | 2 | N | ECX | 101037509 |
| 20161367 | 20062375 | 1.46 | 80.5 | Adjuvant (A) | 2016-12-08 | 2016-12-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100087848 |
| 20161369 | 20062376 | 1.66 | 82.5 | Curative (C) | 2017-12-25 | 2017-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100775739 |
| 20161370 | 20062377 | 1.63 | 56.5 | Palliative (P) | 2018-06-29 | 2018-07-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101231872 |
| 20161371 | 20062378 | 1.54 | 74 | Palliative (P) | 2017-02-26 | 2017-03-27 | ECX | 02 | N | ECX | 100137247 |